New drug target in fight against cancer
- Date:
- September 18, 2019
- Source:
- Rice University
- Summary:
- Researchers have discovered how a cancer-linked version of the protein mitoNEET can close voltage-dependent anion channels (VDAC), primary gateways in the outer surface of mitochondria. The researchers detail how mitoNEET regulates VDAC, and they show that the interactions between the two proteins could be disrupted by a drug that targets VDAC.
- Researchers have identified a potential new drug target in the fight against cancer.In a study this week in the Proceedings of the National Academy of Sciences, an international team of researchers describe how a cancer-linked version of the protein mitoNEET can close the primary gateways in the outer surface of mitochondria, the "power plants" that supply cells with chemical energy. These gateways, or "voltage-dependent anion channels" (VDACs), normally open and close to allow the passage of metabolites and other small molecules between mitochondria and the rest of the cell....https://www.sciencedaily.com/releases/2019/09/190918131516.htm
No comments:
Post a Comment